IN191315B - - Google Patents

Info

Publication number
IN191315B
IN191315B IN698MU2001A IN191315B IN 191315 B IN191315 B IN 191315B IN 698MU2001 A IN698MU2001 A IN 698MU2001A IN 191315 B IN191315 B IN 191315B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Charlotte Moira Norfo Allerton
Christopher Gordon Barber
Keith Michael Devries
Laurence James Harris
Philip Charles Levett
Joanna Teresa Negri
David James Rawson
Albert Shaw Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018660A external-priority patent/GB0018660D0/en
Priority claimed from GB0107526A external-priority patent/GB0107526D0/en
Priority claimed from GB0110251A external-priority patent/GB0110251D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of IN191315B publication Critical patent/IN191315B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN698MU2001 2000-07-28 2001-07-20 IN191315B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018660A GB0018660D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0107526A GB0107526D0 (en) 2001-03-26 2001-03-26 Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
GB0110251A GB0110251D0 (en) 2001-04-26 2001-04-26 Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
IN191315B true IN191315B (zh) 2003-11-22

Family

ID=27255823

Family Applications (1)

Application Number Title Priority Date Filing Date
IN698MU2001 IN191315B (zh) 2000-07-28 2001-07-20

Country Status (17)

Country Link
EP (1) EP1176147A1 (zh)
JP (1) JP2002105076A (zh)
KR (1) KR20020010102A (zh)
CN (1) CN1335317A (zh)
AR (1) AR035650A1 (zh)
AU (1) AU754962B2 (zh)
BR (1) BR0103072A (zh)
CA (1) CA2354175A1 (zh)
CZ (1) CZ20012713A3 (zh)
HK (1) HK1040715A1 (zh)
HU (1) HUP0103075A3 (zh)
IL (1) IL144516A0 (zh)
IN (1) IN191315B (zh)
MX (1) MXPA01007676A (zh)
PL (1) PL348935A1 (zh)
RU (1) RU2224759C2 (zh)
YU (1) YU51701A (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831074B2 (en) 2001-03-16 2004-12-14 Pfizer Inc Pharmaceutically active compounds
GB0106631D0 (en) * 2001-03-16 2001-05-09 Pfizer Ltd Pharmaceutically active compounds
OA13050A (en) 2003-04-29 2006-11-10 Pfizer Ltd 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.
JP2006219373A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
ATE417849T1 (de) 2004-04-07 2009-01-15 Pfizer Pyrazoloä4,3-düpyrimidine
DE602006013688D1 (de) * 2005-11-16 2010-05-27 Hoffmann La Roche Neues verfahren zur herstellung von thoc
JP2009530256A (ja) * 2006-03-17 2009-08-27 シプラ・リミテッド ４−［１−（４−シアノフェニル）−１−（１，２，４−トリアゾール−１−イル）メチル］ベンゾニトリルおよび４−［１−（１ｈ−１，２，４−トリアゾール−１−イル）メチレンベンゾニトリル中間体
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
JP5489997B2 (ja) 2007-07-19 2014-05-14 シマベイ セラピューティクス， インコーポレーテッド 糖尿病および代謝疾患の治療のためのＲＵＰ３またはＧＰＲｌ１９受容体のアゴニストとしてのＮ−アザ環状置換ピロール、ピラゾール、イミダゾール、トリアゾールおよびテトラゾール誘導体
WO2011041154A1 (en) 2009-10-01 2011-04-07 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
CA2802541A1 (en) 2010-06-23 2011-12-29 Metabolex, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
WO2018026890A1 (en) 2016-08-03 2018-02-08 Cymabay Therapeutics Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2089971A (en) * 1937-08-17 Condensation products of
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds

Also Published As

Publication number Publication date
AU754962B2 (en) 2002-11-28
IL144516A0 (en) 2002-05-23
CA2354175A1 (en) 2002-01-28
HK1040715A1 (zh) 2002-06-21
HU0103075D0 (en) 2001-10-28
JP2002105076A (ja) 2002-04-10
HUP0103075A2 (hu) 2002-07-29
PL348935A1 (en) 2002-02-11
RU2224759C2 (ru) 2004-02-27
MXPA01007676A (es) 2002-10-23
KR20020010102A (ko) 2002-02-02
HUP0103075A3 (en) 2003-04-28
YU51701A (sh) 2003-12-31
AU5767201A (en) 2002-01-31
AR035650A1 (es) 2004-06-23
CZ20012713A3 (cs) 2002-04-17
EP1176147A1 (en) 2002-01-30
CN1335317A (zh) 2002-02-13
BR0103072A (pt) 2002-04-09

Similar Documents

Publication Publication Date Title
BE2014C035I2 (zh)
BE2013C060I2 (zh)
BE2012C016I2 (zh)
BE2011C041I2 (zh)
BE2010C009I2 (zh)
BRPI0113085B8 (zh)
BRPI0110940B8 (zh)
BE2014C025I2 (zh)
BRPI0113372A8 (zh)
JP2001356895A5 (zh)
JP2002048673A5 (zh)
JP2001298432A5 (zh)
BR122012015772A2 (zh)
CN3135930S (zh)
CN3141437S (zh)
AU2000280388A8 (zh)
AU2000278679A8 (zh)
AU2000278563A8 (zh)
CN3134543S (zh)
CN3134893S (zh)
CN3135488S (zh)
CN3135489S (zh)
CN3135584S (zh)
AU2000270908A8 (zh)
CN3136262S (zh)